instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: He did not spell out why he expected no corresponding EU moves. But in a statement, his agency said a key finding in its latest annual report was a “marked rise in the potency and purity of Europe’s most commonly used illicit drugs, fuelling concerns for the health of users who, wittingly or unwittingly, may be consuming stronger products”. It also pointed out an increase in the numbers of cannabis-related health emergencies in Europe between 2008 and 2012. Gotz told a briefing arranged to present the European Monitoring Centre for Drugs and Drug Addiction’s report: “In Europe I do not know any government, or parliamentary majority backing a government, that is currently seriously discussing cannabis legalization or regulation in a different way. “I don’t see a discussion coming up of the level as it is in the Americas,” he said in Lisbon, the agency’s headquarters. Portugal pioneered the decriminalization of all drug use in 2001 and some countries have followed suit, making possession of small quantities of drugs, especially marijuana, a misdemeanor rather than criminal offence. Germany allows seriously ill patients to grow, buy and consume their own cannabis under a special license, and medical marijuana is legal in the Czech Republic, but otherwise cultivation and use remain illegal in the EU. In the United States, 23 states and the District of Columbia allow medical marijuana, and voters in four states have gone further by approving the drug for recreational use by adults. But the drug remains illegal under federal law, which classifies pot as a dangerous narcotic with no current medical use. The EU drug monitoring agency said technical innovation and market competition have led to an increase in the potency of cannabis, the purity of cocaine and the MDMA-content in ecstasy tablets. It also flagged market changes such as detection of heroin processing laboratories in Europe and a greater diversification of trafficking routes and opioid products, which, combined with a substantial increase in opium production in Afghanistan, could reverse declines in heroin supply and stagnation of demand. Claim: EU drug agency sees no U.S.-like cannabis legalization moves.
answer:
European Union countries are unlikely to legalize marijuana any time soon as some parts of the United States have done recently, EU drug monitoring agency chief Wolfgang Gotz said on Thursday.


question:
Paragraph: The lawsuits were the latest by states and local governments against drugmaker Purdue Pharma as the country grapples with an opioid epidemic. About a dozen states have also targeted Richard Sackler, the company’s former leader, or members of his family. “Purdue and the Sacklers traded the health and well-being of Californians for profit and created an unprecedented national public health crisis in the process,” California Attorney General Xavier Becerra said at a news conference announcing the legal action by his state. “We will hold them accountable.” Becerra, echoing allegations lodged against Purdue Pharma by others attorneys general across the country, said the company falsely introduced OxyContin in the 1990s as a safe and effective treatment for chronic pain. However, the California’s lawsuit alleges that Purdue and Sackler knew in 1997 that drugs containing oxycodone, such as OxyContin, were widely abused. Still, company representatives marketed it as not being addictive and downplayed the potential for abuse, the suit states. In a statement Monday, Purdue Pharma and former directors of the company denied the allegations and vowed to defend against the “misleading attacks.” It noted that OxyContin represents less than 2% of total opioid prescriptions and is still approved by the U.S. Food and Drug Administration for its intended use as a painkiller as prescribed by doctors and dispensed by pharmacists. “Such allegations demand clear evidence linking the conduct alleged to the harm described,” spokesman Robert Josephson said in a statement. “But we believe the state fails to show such causation and offers little evidence to support its sweeping legal claims.” A spokesman for Sackler did not immediately respond to a request for comment. The family has faced a backlash in recent years amid a growing public outcry around opioid addiction. In addition, activists have targeted institutions, such as the Metropolitan Museum of Art, that the family has supported through large contributions. The museum has said it will no longer take money from members of the family linked to the drugmaker. Purdue stopped marketing OxyContin to doctors last year. It settled a lawsuit by the state of Oklahoma in March for $270 million. The company previously said it is pursuing several options, including bankruptcy, which could upend pending litigation by states as well as about 2,000 local and tribal governments across the country. The lawsuits filed Monday allege that Purdue Pharma pushed doctors to prescribe opioids for longer periods of time at higher doses. “Our complaint alleges that their unrelenting sales visits to doctors and deceptive practices led to a marked increase in opioid prescriptions, and a corresponding increase in the number of Mainers suffering from opioid use disorder,” Maine Attorney General Aaron M. Frey said. Maine’s lawsuit names Richard Sackler, Jonathan Sackler, Mortimer D.A. Sackler and Kathe Sackler — all of whom have served on the board of Stamford, Connecticut-based Purdue Pharma. States have also cracked down on doctors who overprescribe the drug. Hawaii Attorney General Clare Connors said in a statement Monday that she has filed lawsuits alleging violations of Hawaii’s Unfair and Deceptive Acts and Practices Law. One complaint alleges Purdue deceptively marketed OxyContin and other opioids. Another says manufacturers and distributors sold more opioids than could be “legitimately prescribed.” Meanwhile, the Centers for Disease Control and Prevention said opioids are the main driver of drug overdose deaths. Opioids were involved in 47,600 overdose deaths in the U.S. in 2017, according to the agency. In 2017, it says, prescription opioids were involved in 1,172 overdose deaths in California; 100 overdose deaths in Maine; and 58 in the District of Columbia. Maine set a state record for total drug overdose deaths in 2017 with 417. Jordan Basileu joined Becerra in announcing California’s lawsuit. He said he was prescribed opioid painkillers at 18 following a car crash and became addicted. “People think, ‘it’s from a doctor. How bad can it be?’” Basileu said of the drug. Basileu said he overdosed four times before getting sober three years ago. “I’m still cleaning up the mess that opioids got me in to,” he said. ___ Associated Press reporters Adam Beam and Caleb Jones contributed to this story. Jones reported from Honolulu. Claim: More states sue opioid maker alleging deceptive marketing.
answer:
California, Hawaii, Maine and the District of Columbia filed lawsuits Monday against the maker of OxyContin and the company’s former president, alleging the firm falsely promoted the drug by downplaying the risk of addiction while it emerged as one of the most widely abused opioids in the U.S.


question:
Paragraph: Ravalli County District Judge Jennifer Lint signed a temporary restraining order Friday that prohibits Gov. Steve Bullock and state health officials from enforcing emergency rules on flavored vaping products. They were set to take effect Tuesday. Lint was acting in response to a lawsuit filed Thursday by three vape shops and an industry group. They claim the 120-day ban is an overly restrictive reaction to a national outbreak of vaping-related illnesses and deaths they say is caused by illegal black-market products. Bullock’s press secretary, Erin Loranger, told the Ravalli Republic that officials are reviewing the judge’s ruling. The lawsuit was brought by the Montana Smoke Free Association, Freedom Vapes, Liberty Smoke and uBlaze Vapor said the ban could force more than 20 Montana businesses to close. The business owners said the pulmonary illnesses could be the result of the “illicit addition” of THC or marijuana products into legal vaping products. THC and marijuana are not included as ingredients in any of the products sold by the businesses involved in the lawsuit, according to the plaintiffs. The ban would not only harm the businesses, but also people who use e-cigarettes to quit tobacco products, the lawsuit said. In an affidavit filed in the lawsuit, Freedom Vapes owner Ron Marshall said that flavored vape juices comprise 95% of the products sold in his three stores and his business would not be able to survive without them. On Friday, he said that the lawsuit was about freedom and liberty. “If the governor can take away those liberties with a swipe of a pen, then what’s next? If it’s us today, who will it be tomorrow?” he said. Lint scheduled an Oct. 30 hearing to consider arguments about the future of the temporary ban. ___ Information from: Ravalli Republic , http://www.ravallirepublic.com Claim: Montana judge halts temporary flavored vaping ban.
answer:

Show your work and conclude with the exact phrasing "Therefore, the final answer is [answer]." where [answer] is just the final number or expression that solves the problem.
user
A temporary ban on the sale of flavored electronic cigarettes due to take effect next week in Montana has been blocked for now by a judge.


